APA (7th ed.) Citation

Burger, D. M., Schwietert, H. R., Colbers, E. P. H., & Becker, M. (2006). The effect of the CYP2C19* 2 heterozygote genotype on the pharmacokinetics of nelfinavir. British Journal of Clinical Pharmacology, 62(2), 250. https://doi.org/10.1111/j.1365-2125.2006.02635.x

Chicago Style (17th ed.) Citation

Burger, David M., H. Reinier Schwietert, E. P. H. Colbers, and Mark Becker. "The Effect of the CYP2C19* 2 Heterozygote Genotype on the Pharmacokinetics of Nelfinavir." British Journal of Clinical Pharmacology 62, no. 2 (2006): 250. https://doi.org/10.1111/j.1365-2125.2006.02635.x.

MLA (9th ed.) Citation

Burger, David M., et al. "The Effect of the CYP2C19* 2 Heterozygote Genotype on the Pharmacokinetics of Nelfinavir." British Journal of Clinical Pharmacology, vol. 62, no. 2, 2006, p. 250, https://doi.org/10.1111/j.1365-2125.2006.02635.x.